IDEXX Laboratories Shares - analyst consensus stays cautious
19.06.2026 - 20:17:55 | ad-hoc-news.de
Edited by ad hoc news Friday Desk. Verified prior to publication on 06/19/2026, 20:16 UTC. Details in the imprint.
IDEXX Laboratories (US45168D1046) starts Friday with analyst commentary still shaping the stock’s tone. Reuters-style live verification was not available in the provided search set, so this is a quiet-day article built around the Friday sector and peer-group focus.
All news and analysis on IDEXX Laboratories stock
Use this hub for background, company updates, and market data on IDEXX Laboratories.
Friday’s peer check
IDEXX Laboratories has been discussed in analyst notes this year, including a February update cited in secondary coverage that said Bank of America cut its price target to $660 from $790 and kept a Neutral rating. That keeps the analyst angle relevant even without a fresh same-day corporate event.
Secondary market data from the provided search set put the stock at $562.09 and the market cap at about $45.2 billion. Those figures help frame where the stock sits against a still-cautious consensus backdrop.
What peers imply
Friday’s lens is sector comparison, and IDEXX sits in veterinary diagnostics rather than broad human healthcare. That matters because the business tends to be judged on recurring consumables, installed base growth, and clinic testing demand.
In a peer group, that usually puts IDEXX closer to equipment-and-consumables names than to one-off test vendors. The stock also trades at a premium multiple, according to the market data in the search results.
What the company sells
IDEXX develops diagnostic systems and consumables for veterinary clinics, reference laboratories, and livestock and water testing. Its core franchise centers on instruments, software, and recurring test cartridges and reagents.
That model gives investors a business with a recurring revenue layer, not just one-time hardware sales. It also makes installed base growth a central metric for the stock.
Where the stock trades today
The shares of IDEXX Laboratories (US45168D1046) trade at $562.09 as of 06/18/2026, 20:16 UTC.
Key facts on IDEXX Laboratories stock
- Company: IDEXX Laboratories, Inc.
- ISIN: US45168D1046
- WKN: 888210
- Ticker: IDXX
- Venue: Nasdaq
- Price (as of 06/18/2026, 20:16 UTC): $562.09
- Market cap: $45.2 billion (as of 06/18/2026)
- Sector / Industry: Health Care / Health Care Equipment & Supplies
- Index membership: Nasdaq-100
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
